Molecular biology of mesothelioma: Implications for the development of new targeted therapies PET1

Date 27 March 2014
Event ELCC 2014
Session Mesothelioma: Standards and controversies
Topics Mesothelioma
Pathology/Molecular Biology
Presenter Marc Ladanyi
Authors M. Ladanyi
  • Pathology, Memorial Sloan Kettering Cancer Center, 10065 - New York, NY/US